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to be weaned off hemodialysis along with 
the benefit of concurrent amelioration of 
renovascular hypertension. 
Conclusion: For select patients with 
RAO there can benefits, such as achieving 
dialysis independence and stabilization of 
renovascular hypertension, by attaining 
revascularization of the renal arteries despite 
prolonged time of ischemia. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.041
No Survival Advantage Exists for Patients Undergoing Loop Ileostomy for Clostridium difficile Colitis
Bradley R. Hall, Andrew Cannon, Pranita Atri, Christopher S. Wichman, Lynette M. Smith, Apar K. 
Ganti, Chandrakanth Are, Aaron R. Sasson, Sushil Kumar, Surinder K. Batra
Mentor: Dmitry Oleynikov
Program: General Surgery 
Background & Objectives: Loop ileostomy 
(LI) remains an unproved alternative to total
abdominal colectomy (TAC) for patients
with Clostridium difficile infection (CDI).
We aim to compare outcomes between loop
ileostomy and total abdominal colectomy for
Clostridium difficile infection using a national
database.
Methods: The 2011-2016 ACS-NSQIP 
database was queried for patients who 
underwent LI or TAC for CDI. Patients with 
high outlying age, LOS, and operative time 
were excluded. Statistics were performed 
using IBM SPSS and NCSS PASS 11.
Results: Of 457 patients identified, 47 
underwent LI. Predicted morbidity was higher 
in the TAC cohort (62% vs. 37%, p<0.001). 
Patients in the LI cohort experienced fewer 
complications (72% vs. 87%, p=0.021); 
however, mortality did not differ between 
LI (36%) and TAC (31%) cohorts. Blood 
transfusions were more than twice as 
frequent in the TAC cohort (54% vs. 19%, 
p<0.001). Four patients in the LI cohort 
required reoperation; however, none required 
colectomy. 
Conclusions: Compared to TAC, LI does not 
improve survival for patients who require 
surgical intervention for CDI. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.042
Advanced Pancreatic Cancer: A Meta-Analysis of Clinical Trials over Thirty Years
Bradley R. Hall, Jennifer A. Leinicke, Priscila R. Armijo, Lynette M Smith, Sean J. Langenfeld, Dmitry Oleynikov
Mentor: Surinder Batra
Program: General Surgery 
Background & Objectives: In contrast to 
other cancers, survival rates for pancreatic 
ductal adenocarcinoma (PDAC) have 
improved but minimally over the past thirty 
years. The aim of this study was to perform a 
meta-analysis of clinical trials published since 
1986 to determine trends in median overall 
survival in primarily metastatic PDAC.
Methods: All Phase 2-4 clinical trials 
published during or after 1986 investigating 
first-line systemic chemotherapy in metastatic 
PDAC were included in the meta-analysis. 
Publications obtained through PubMed and 
www.ClinicalTrials.gov were cross-referenced 
to identify additional trials. Trials enrolling 
fewer than 50% of study participants with 
metastatic disease were excluded. 
Results: Of 19,488 patients enrolled in 151 
clinical trials, 84% had metastatic disease 
and 16% had locally advanced pancreatic 
cancer. In clinical trials published from 1986 
to 2016, the weighted median overall survival 
(wMOS) increased by 3.0 months. The 
median wMOS was higher in combination 
therapy (7.31 months, IQR 5.4 to 8.5) 
compared to non-gemcitabine, single-agent 
therapy (4.76 months, IQR 3.5 to 6.0), 
gemcitabine monotherapy (6.48 months, IQR 
5.9 to 7.2), and gemcitabine plus single-agent 
therapy (7.09 months, IQR 6.3 to 8.2). Of all 
regimens used in more than one study arm, 
FOLFIRINOX had the highest wMOS (10.9 
months). 
Conclusions: Regardless of treatment 
regimen, survival rates in PDAC have 
minimally improved over time. Of drugs 
used in two or more study arms, only 
FOLFIRINOX has a wMOS greater than ten 
months. Emphasis should, therefore, be placed 
on identification of novel targets that promote 
early diagnosis and intervention. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.043
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Background: The management and prognosis 
of pancreatic adenocarcinoma varies 
depending on the location of the primary 
lesion within the pancreas. There is a paucity 
of data on survival trends in pancreatic 
adenocarcinoma based on the location. The 
49 
aim of this study was to analyze the national 
trends in survival for patients with pancreatic 
adenocarcinoma based on the location of the 
primary lesion. 
Methods: The Surveillance, Epidemiology, 
and End Results (SEER) database (SEER 17, 
1973-2007) was used to identify patients with 
pancreatic cancer located in the head (C25.0), 
body (C25.1), or tail (C25.2). SEER*Stat 
6.6.2 was used to calculate 5-year survival 
data. To stabilize rates, we used 5-year cohorts 
when calculating trends. 
Results: A total of 89,733 patients were 
included in the study. The overall 5-year 
survival, inclusive of all locations and 
treatment approaches was is 5.4% (95% CI 
5.2-5.6%). For lesions in the head, body and 
tail the overall 5-year survival, inclusive of 
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all treatment approaches, was 5.2% (95% CI 
5-5.5%), 3.9% (95% CI 3.4-4.4%) and 7.8%
(95% CI 7.2-8.5%) respectively. For patients
that underwent surgery, the 5-year survival
for patients with lesions in all locations, head,
body and tail was 18.8%, 15.9%, 23.8%
and 33.8% respectively. When analyzing
trends we noted a significant improvement in
survival for patients that underwent operative
intervention. Comparing the time periods 
from 1977-1981 versus 2002-2006, the 5-year 
survival for surgical patients improved for 
all locations (9.2% to 22.6%, p<0.05) and 
also for lesions in the head (8.3% to 19.3%, 
p<0.05), body (6.7% to 26%, p<0.05) and tail 
(14.7% to 40.7%, p<0.05). 
Conclusion: The results of our study 
demonstrate an improvement in survival for 
patients with pancreatic cancer treated by 
operative intervention. This improvement in 
survival was more pronounced for patients 
with primary lesions located in the body and 
tail. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.044
Global Trends in Esophageal Cancer
Gautam K. Malhotra, Ujwal Yanal, Advaitaa Ravipati, Matthew Follet, M. Vijayakumar, Chandrakanth Are
Mentor: Chandrakanth Are
Program: General Surgery 
Background & Objectives: Esophageal 
Cancer (EC) is a lethal malignancy with poor 
prognosis and significant variations in the 
incidence, mortality, and histopathology based 
on geographic regions. The aim of this study 
was to quantitatively analyze these variations 
to identify patterns and areas for further 
research.
Methods: We utilized the GLOBOCAN 2012, 
and Cancer Incidence in five Continents, 
Volume X (CI5X) database to analyze 
variations in EC incidence and mortality.
Results: We found the EC incidence and 
mortality is geographically varied with a 
particularly high burden in East Asia and 
Eastern/Southern Africa where esophageal 
squamous cell carcinoma (SCC) predominates 
over adenocarcinoma (AC). Interestingly, 
there is a dichotomy between the high 
incidence of esophageal SCC in East Africa 
and low incidence in West Africa. The global 
incidence and mortality from EC is expected 
to rise in the coming decades. Asia, and 
China in particular, will continue to be the 
areas most burdened by EC, while Africa 
is expected to surpass the incidence and 
mortality rates of Europe.
Conclusions: The global burden of EC 
is expected to rise in the coming years. 
Understanding the geographic, environmental, 
and genetic contributors to the development 
of EC will be essential in combating its 
prevalence. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.045
Outcomes of Intragastric Balloon Placements: An Analysis of the 2016 MBSAQIP Database
Bhavani Pokala, Priscila Armijo, Dmitry Oleynikov
Mentor: Dmitry Oleynikov
Program: General Surgery 
Background & Objectives: Intragastric 
balloon placement is an approved weight-
loss procedure with a lower BMI cutoff than 
bariatric surgery. The objective of this study 
was to examine the frequency and outcomes 
of balloon placements in 2016.
Methods: The MBSAQIP database was 
analyzed for adults who underwent elective, 
endoscopic intragastric balloon placement. 
Emergent cases, patients with previous foregut 
surgery and those unable to be followed for 
30 days were excluded. Comparisons were 
made between placements performed by GI 
and surgery. Analysis performed using SPSS 
v25.0, α=.05. 
Results: Our study included 445 patients. 
Majority were female (80%) and Caucasian 
(90.6%). Median age and BMI were 49.0 
(IQR 15.4) and 35.7 (IQR 6.46), respectively. 
Prevalence of medically treated hypertension 
was 30.8%, hyperlipidemia 18.9%, GERD 
20.4%, and diabetes 12.6% (insulin and 
non-insulin dependent). Mean operative 
time was 15.48 ± 9.89 minutes. No 30-day 
mortalities were reported. 70 balloons were 
placed by GI and 375 by surgery. There was a 
significantly higher rate of readmission for GI 
7.1% vs 1.9% surgery (p=.027). No significant 
difference was seen for rates of post-operative 
dehydration (GI: 7.1% vs surgery: 7.2%; 
p=1.000), emergency room encounters (GI: 
14.0% vs surgery: 4.0%; p=.486), 30-day 
reoperations (GI: 0.0% vs surgery: 0.8%; 
p=1.000), and 30-day reinterventions (GI: 
5.7% vs surgery 2.4%; p=.132). 
Conclusions: The majority of patients 
undergoing intragastric balloon placement 
fall within obesity class 1 or 2 and have low 
rates of comorbidities. The procedure can be 
performed by gastroenterology or surgery at 
bariatric centers with similar outcomes.  
https://doi.org/10.32873/unmc.dc.gmerj.1.1.046
Development of a Porcine Model of Severe Noncompressible Truncal Hemorrhage 
Ujwal Yanala, Jason Johanning, Iraklis Pipinos, William Velander, Mark Carlson 
Mentor: Mark Carlson
Program: General Surgery 
Introduction: Noncompressible truncal 
hemorrhage and brain injury account for most 
early mortality in military personnel on the 
battlefield. Currently there is no effective 
treatment for noncompressible truncal 
hemorrhage, other than rapid evacuation to 
a surgical facility. We intended to develop a 
porcine model of noncompressible truncal 
hemorrhage so that we might be able to 
develop new treatments for this clinical 
problem. 
Methods: Swine (boars, 3 months, 32-34 kg) 
underwent one of three injury types: 1) central 
stellate injury, just anterior to suprahepatic 
inferior vena cava (N=6); 2) excision of a 
portal vein branch distal to the main trunk 
(N=5); or 3) near-transection of the left lateral 
lobe (LLL) of the liver at its base, which 
cut the hepatic and portal veins to this lobe 
(N=12). The midline incision was towel 
clipped immediately after injury, and animals 
were monitored for 60 min or until death. 
Resuscitation was performed with warm LR 
(max volume = 100 mL/kg), with a target 
MAP set at 80% of pre-injury MAP. 
Results: The starting weight, MAP, 
hemoglobin, arterial pH, INR, and pre-injury 
blood loss did not differ among groups (p 
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